Asset Management One Co., Ltd. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Asset Management One Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$64.07 - $91.75 $655,500 - $938,694	-10,231 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$65.07 - $98.24 $973,772 - $1.47 Million	-14,965 Reduced 59.39%	10,231 $884,000
Q1 2020 May 14, 2020	SELL	$27.51 - $57.29 $831,847 - $1.73 Million	-30,238 Reduced 54.55%	25,196 $857,000
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $729,919 - $966,000	19,527 Added 54.38%	55,434 $2.31 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $1.43 Million - $2.41 Million	35,907 New	35,907 $1.57 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Asset Management One Co., Ltd. with notifications on news.